Evidence map›Paper›PMID 27480939›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2016

Inhibitory effect of YM-244769, a novel Na

Kanna Yamashita, Yasuhide Watanabe, Satomi Kita, Takahiro Iwamoto, Junko Kimura

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. L-type CaPhysiological reports · 2022
    Article
  3. Pinacidil, a KATP channel opener, stimulates cardiac NaNaunyn-Schmiedeberg's archives of pharmacology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Kanna YamashitaDivision of Pharmacological Science, Department of Health Science, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Yasuhide WatanabeDivision of Pharmacological Science, Department of Health Science, Hamamatsu University School of Medicine, Hamamatsu, Japan. w-yasu@hama-med.ac.jp.
Satomi KitaDepartment of Pharmacology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Takahiro IwamotoDepartment of Pharmacology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Junko KimuraDepartment of Pharmacology, School of Medicine, Fukushima Medical University, Fukushima, Japan.
Fukuoka University · JPHamamatsu University School of Medicine · JPFukushima Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, YM-244769 (N-(3-aminobenzyl)-6-{4-[(3-fluorobenzyl)oxy]phenoxy} nicotinamide) has been reported as a new potent and selective Na

Indexed as

AnimalsCalciumDose-Response Relationship, DrugGuinea PigsHeart VentriclesMembrane PotentialsMembrane Transport ModulatorsMyocytes, CardiacNiacinamidePatch-Clamp TechniquesSodiumSodium-Calcium ExchangerTime FactorsTrypsinCalciumMembrane Transport ModulatorsN-(3-aminobenzyl)-6-(4-((3-fluorobenzyl)oxy)phenoxy)nicotinamideNiacinamideSodiumSodium-Calcium ExchangerTrypsinBenzyloxyphenyl derivativeCardiac myocytesMembrane currentNa+/Ca2+ exchange current (INCX)Patch-clamp methodYM-244769

Identifiers

PMID27480939
OpenAlexW2479886428

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.